Hoc-trade opens TradeMedic behavioral analytics to retail traders

Hoc-trade launched a subscription version of TradeMedic for individual traders with MT4 or MT5 accounts, giving retail users access to AI-driven behavioral analytics once used mainly by professional trading desks. The company says the tool can diagnose execution habits, flag trading psychology issues and suggest corrective steps to improve performance. Why it matters: - Retail traders often rely on win/loss totals or gut feel to judge performance, which can miss behavior patterns that hurt returns over time. - TradeMedic brings behavioral analytics used in institutional trading into a tool individual traders can use on their own accounts. - The launch is aimed at helping traders identify execution mistakes, reduce capital leaks and improve discipline. What happened: - Hoc-trade made TradeMedic accessible to any trader with an MT4 or MT5 account. - The launch expands access through a new subscription model for individual traders. - The platform is now available for retail users who want AI-powered diagnostic reports on trading behavior. The details: - TradeMedic analyzes raw execution data to produce behavioral teardowns and health scores. - The platform is broker-agnostic, so traders can use it across exchanges, platforms and asset classes. - Hoc-trade says the system can identify patterns such as revenge trading, premature profit-taking, risk aversion and FOMO-related behavior. - The tool provides targeted, AI-driven recommendations intended to correct behavioral flaws and improve future execution. - Traders can run their first self-diagnostic report starting today. - The platform can be accessed at the login page . Between the lines: - The launch reflects a push to make professional-style trading analytics available to smaller accounts. - Hoc-trade is positioning trading psychology as a measurable performance factor, not just a soft skill. - CEO Jonas Schleypen said the company wants to democratize behavioral analytics and give every trader access to clinical-grade tools. What’s next: - Traders can start a free trial, review performance case studies and begin using the platform immediately. - Hoc-trade is likely betting that retail demand for more objective performance feedback will drive adoption beyond institutional users. The bottom line: - TradeMedic now gives retail traders a data-driven way to evaluate trading habits and act on them, not just review outcomes.